| Serial Number | 79376322 |
| Word Mark | INTELLECTIVE |
| Filing Date | Tuesday, June 13, 2023 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, October 14, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 19, 2024 |
| Goods and Services | Pharmaceutical products for treating cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions; medical preparations for the treatment of cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions; veterinary preparations for vaccinating livestock; disinfectants; preparations for destroying vermin; fungicides; herbicides; dietetic food and beverages adapted for medical use; dietetic pet foods and beverages for veterinary use; food for babies; food supplements; medical plasters, medical dressings; medicines for treating cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions |
| Goods and Services | Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions; chemicals for use in industry and science; reagents for scientific apparatus for chemical or biological analyses being reagents for scientific and research use; protein in raw material form for scientific and medical research; biochemicals for in-vitro and in-vivo scientific use; biological preparations for use in industry and science; chemical preparations for use in industry; catalysts for chemical processes; diagnostic preparations for scientific use; diagnostic reagents for science or research use; stem cells for research purposes |
| Goods and Services | Research and development of new pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; providing information with respect to medical and scientific research in the field of pharmaceutical products; pharmaceutical research and development services; consultation with respect to pharmaceutical research; medical research; scientific research services for medical purposes in the field of pharmaceuticals; biomedical research services; scientific and medical research and development, namely, research and development in the field of medical preparations; design and development of testing and analysis methods for new pharmaceutical product development; scientific research in the nature of conducting clinical trials for others; analysis and evaluation of newly developed pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; analysis and evaluation of newly designed pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; stem cell research services; scientific research services for medical purposes in the field of proteins, antibodies, microorganisms and cells; product research; providing medical and scientific research information in the field of pharmaceutical products and clinical trials; providing information on the results of clinical research trials for pharmaceutical products; consultation with respect to pharmaceutical research and development; providing integrated development of pharmaceutical products, namely, research and development of pharmaceutical products, and scientific research in the nature of conducting clinical trials and studies for others |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 11, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 11, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 11, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Intellective Biologics (Suzhou) Co., Ltd. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Party Name | NaTurtle AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Event Date | Event Description |
| Friday, August 11, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, October 27, 2023 | CHANGE OF OWNER RECEIVED FROM IB |
| Thursday, August 10, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, August 15, 2023 | APPLICATION FILING RECEIPT MAILED |
| Sunday, December 10, 2023 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Monday, March 4, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 27, 2024 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
| Thursday, April 4, 2024 | REFUSAL PROCESSED BY MPU |
| Monday, March 4, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, March 5, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, April 2, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 3, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, April 23, 2024 | REFUSAL PROCESSED BY IB |
| Monday, September 16, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 16, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 16, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, October 5, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 13, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, April 4, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |